ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
DiagnosesAplastic Anemia

Aplastic Anemia

ICD-10 Coding for Aplastic Anemia(D61.0, D61.1, D61.9)

PRIMARY SPECIALTYHematology
COMPLEXITYHigh
LAST UPDATED09/15/2025
Sam Tuffun, PT, DPT
Physical Therapist | Medical Coding & Billing Contributor

Diagnosis Overview

What is Aplastic Anemia?
Essential facts and insights about Aplastic Anemia

Key Clinical Considerations:

  • Patients typically present with symptoms such as fatigue, pallor, and increased susceptibility to infections.
  • Laboratory findings include a significant reduction in all three blood cell types (red blood cells, white blood cells, and platelets) as evidenced by complete blood count (CBC).
  • Physical examination may reveal signs of anemia, such as pallor, and signs of bleeding or bruising due to thrombocytopenia.
  • Imaging studies are generally not required for diagnosis but may be used to rule out other conditions.
  • Severity is often classified based on the degree of cytopenias and the presence of symptoms, with criteria established by the International Aplastic Anemia Study Group.

Clinical Information

Clinical Criteria & Documentation Requirements

  • Medical records must document the patient's symptoms, laboratory results, and any relevant medical history.
  • Specific terminology such as 'hypocellular bone marrow' and 'pancytopenia' must be included in the documentation.
  • Examples include noting the CBC results and any bone marrow biopsy findings that support the diagnosis.
  • Documentation must demonstrate medical necessity for tests and treatments related to aplastic anemia.
  • Quality measures may include tracking the patient's response to treatment and any complications arising from the condition.

Coding Guidelines

Usage Guidelines & Examples

  • Use D61.0 for acquired aplastic anemia due to known causes such as medications or infections.
  • Do not use this code for aplastic anemia secondary to other hematological disorders or malignancies.
  • D61.1 is used for aplastic anemia of unspecified origin, while D61.9 is for unspecified aplastic anemia.
  • Common coding errors include misclassifying the type of aplastic anemia or failing to document the underlying cause.
  • In complex cases, ensure to review the patient's full medical history and laboratory results to select the most accurate code.

Code Exclusions

Important Exclusions

  • Excludes aplastic anemia secondary to known causes such as chemotherapy or radiation exposure.
  • Alternative codes for excluded conditions include those for myelodysplastic syndromes or other bone marrow disorders.
  • Conditions are excluded to ensure accurate coding and appropriate treatment pathways.
  • Common mistakes include misclassifying secondary aplastic anemia as primary.
  • Related but distinct conditions include pure red cell aplasia and other forms of bone marrow failure.

Related ICD-10 Codes

Primary Codes
D61.0
Acquired aplastic anemia
D61.1
Aplastic anemia due to other specified causes
D61.9
Aplastic anemia, unspecified
Ancillary Codes
T45.1X5A
Cxx.x
Differential Codes
D61.1
D61.1
when aplastic anemia is due to radiation or chemotherapy, not drugs.
D61.0
D61.0
when aplastic anemia is due to specific drugs or chemicals.

Related CPT Codes

CPT codes will be available in a future update.

Specialty Focus

Primary Specialty

Hematology

Specialty Applications

  • This diagnosis applies to patients with bone marrow failure syndromes.
  • Patient populations include all ages, but it is more common in young adults and those exposed to certain environmental factors.
  • Clinical settings include hematology clinics, inpatient settings for severe cases, and outpatient follow-up care.
  • Specialty-specific applications are primarily in hematology and oncology.
  • Treatment contexts include management of severe cases requiring transfusions or bone marrow transplantation.

Coding Complexity

High Complexity

This diagnosis requires careful attention to:

  • Comprehensive clinical documentation
  • Accurate code selection based on clinical criteria
  • Proper exclusion considerations
  • Specialty-specific coding guidelines

Documentation

Documentation Templates

Template 1

Template: 'Patient diagnosed with aplastic anemia based on clinical findings of fatigue and CBC results showing pancytopenia.'

Template 2

Template: 'Clinical presentation consistent with aplastic anemia including symptoms of weakness and recurrent infections.'

Template 3

Template: 'Diagnostic criteria for aplastic anemia met as evidenced by bone marrow biopsy showing hypocellularity.'

Template 4

Template: 'Treatment plan initiated for aplastic anemia with supportive care and consideration for bone marrow transplant.'

Template 5

Template: 'Follow-up care for aplastic anemia including monitoring of blood counts and response to treatment.'

Billing Information

Billing Considerations

  • Ensure proper documentation for billing
  • Verify code specificity requirements
  • Check for any additional codes needed
  • Review payer-specific guidelines

Common Issues

  • Insufficient clinical documentation
  • Incorrect code selection
  • Missing supporting diagnoses
  • Timing and frequency documentation

Frequently Asked Questions

What documentation is required for this diagnosis?

Documentation must include clinical findings, laboratory results, and any relevant medical history.

How does this differ from similar diagnoses?

Aplastic anemia is characterized by a reduction in all blood cell types, unlike other anemias which may only affect red blood cells.

What are common billing considerations?

Ensure that the diagnosis is clearly linked to the services provided to optimize reimbursement.

What procedures are typically associated?

Commonly associated procedures include bone marrow biopsy and transfusions.

Are there any quality reporting implications?

Quality measures may include tracking treatment outcomes and complications related to aplastic anemia.